Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 01/03/2011
PIL Salagen 5 mg Film Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 14/12/2010 and displayed until 01/03/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 30/12/2008 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 12/04/2008 and displayed until 30/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 09/01/2008 and displayed until 12/04/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 12/09/2007 and displayed until 09/01/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 13/04/2007 and displayed until 12/09/2007
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 26/05/2005 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to packaging
Updated on 12/01/2005 and displayed until 26/05/2005
Reasons for adding or updating:
  • Change of manufacturer
Updated on 05/06/2003 and displayed until 12/01/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   pilocarpine hydrochloride